STARRT-AKI 试验中与不良血流动力学事件相关的因素:事后二次分析
该研究为 STARRT-AKI 试验的多国事后二次分析,评估接受肾脏替代治疗(RRT)患者发生不良血流动力学事件(HAE)的相关因素,以及 HAE 与临床结局的关系。主要分析采用基于 LASSO 的多变量 Cox 比例风险模型,以 HAE 发生时间为因变量。结果显示,RRT 启动时 SOFA 评分较高(HR 1.05;95%CI 1.00-1.10)、初始采用 IHD 相比 CRRT(HR 1.74;95%CI 1.28-2.37)及初始采用 SLED 相比 CRRT(HR 2.73;95%CI 1.65-4.51)与 HAE 风险增加显著相关。多变量分析中,HAE 发生与死亡、透析依赖、住院时间、无 RRT 天数、无呼吸机天数或无血管活性药天数均无显著关联,但多次 HAE 与 90 天全因死亡显著相关。
要点
- 初始 RRT 模式与 HAE 风险相关:相比 CRRT,初始 IHD 的 HR 为 1.74(95%CI 1.28-2.37),初始 SLED 的 HR 为 2.73(95%CI 1.65-4.51)。
- RRT 启动时 SOFA 评分每升高 1 分,HAE 风险 HR 为 1.05(95%CI 1.00-1.10)。
- 单次 HAE 与死亡、透析依赖、住院时间、无 RRT 天数、无呼吸机天数及无血管活性药天数均无显著关联。
- 该分析为 STARRT-AKI 试验的事后二次分析,结果需结合原始试验背景解读。
适用人群与场景
- STARRT-AKI 试验中接受肾脏替代治疗(RRT)的 ICU 患者。
研究设计与关键结果
- 研究类型:STARRT-AKI 试验的多国事后二次分析。
- 主要分析:基于 LASSO 的多变量 Cox 比例风险模型,以 HAE 发生时间为因变量。
- 与 HAE 风险增加显著相关的因素:RRT 启动时 SOFA 评分较高(HR 1.05;95%CI 1.00-1.10);初始 RRT 模式为 IHD 相比 CRRT(HR 1.74;95%CI 1.28-2.37);初始 RRT 模式为 SLED 相比 CRRT(HR 2.73;95%CI 1.65-4.51)。
- 调整基线患者特征和 RRT 启动协变量后,HAE 发生与死亡、透析依赖、住院时间、无 RRT 天数、无呼吸机天数、无血管活性药天数均无显著关联。
- 多次 HAE 与 90 天全因死亡显著相关。
证据类型、等级与局限
- 证据类型:STARRT-AKI 试验的事后二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在 ICU 启动 RRT 时,初始选择 IHD 或 SLED 相比 CRRT 与更高的 HAE 风险相关,选择模式时可参考此关联。
- SOFA 评分较高的患者启动 RRT 时 HAE 风险略高(HR 1.05),需注意监测血流动力学。
- 单次 HAE 未显著关联不良临床结局,但多次 HAE 与 90 天全因死亡显著相关,应关注 HAE 的反复发生。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Haemodynamic adverse events related to renal replacement therapy are a complication of all RRT modalities used in the ICU, including intermittent haemodialysis (IHD), sustained low efficiency dialysis (SLED) and continuous renal replacement therapy (CRRT). At present it is unclear which risk factors predispose to HAE and whether these contribute to adverse patient outcomes.
METHODS: We performed a secondary analysis of the multinational STARRT-AKI trial to assess factors associated with the occurrence of haemodynamic adverse events (HAE) in patients receiving RRT and whether these HAE were associated with less favourable clinical outcomes. The primary analysis was a multivariable Cox proportional hazards model based on the least absolute shrinkage and selection operator (LASSO), which included time to HAE as the dependent variable.
RESULTS: Factors significantly associated with an increased hazard ratio (HR) for HAE during RRT were a higher SOFA score at RRT initiation (HR 1.05; 95% 1.00-1.10), use of IHD as the initial RRT modality in comparison to CRRT (HR 1.74; 95% CI 1.28-2.37) and use of SLED as the initial RRT modality in comparison to CRRT (HR 2.73; 95% CI 1.65-4.51). In a multivariable analysis, adjusted for baseline patient characteristics and RRT initiation covariates, there was no significant association between the occurrence of a HAE during RRT and mortality, dialysis dependence, length of stay, RRT-free days, ventilator-free days or vasoactive-free days, respectively. There was, however, a significant association between multiple haemodynamic adverse events and all-cause mortality at 90 days.
CONCLUSIONS: In this secondary analysis of the STARRT-AKI trial, the use of intermittent RRT modalities and higher severity of illness were associated with HAE during RRT. These events were not significantly associated with adverse clinical outcomes, apart from a significant association between multiple HAE and all-cause mortality at 90 days.
参考来源
- Kelly YP, da Costa BR, Beaubien-Souligny W, et al. Factors associated with adverse haemodynamic events during the STARRT-AKI trial: a post-hoc secondary analysis. Crit Care. 2025. PMID: 41466322. doi:10.1186/s13054-025-05693-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。